800
Participants
Start Date
April 30, 2005
Primary Completion Date
August 31, 2014
Study Completion Date
June 30, 2019
asparaginase
cyclophosphamide
cytarabine
dexamethasone
dexrazoxane hydrochloride
doxorubicin hydrochloride
etoposide
Given IV
leucovorin calcium
mercaptopurine
Given orally
methotrexate
methylprednisolone
pegaspargase
Given IV
prednisolone
therapeutic hydrocortisone
vincristine sulfate
radiation therapy
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York
Albert Einstein Cancer Center at Albert Einstein College of Medicine, The Bronx
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
Dana Farber Cancer Institute, Boston
Hasbro Children's Hospital, Providence
McMaster Children's Hospital at Hamilton Health Sciences, Hamilton
Hopital Sainte Justine, Montreal
Centre de Recherche du Centre Hospitalier de l'Universite Laval, Sainte-Foy
National Cancer Institute (NCI)
NIH
Dana-Farber Cancer Institute
OTHER